Osaka, Japan

Fujimoto Pharmaceutical Corporation

USPTO Granted Patents = 8

% Expired Patents = 50.0



Forward Citations = 34

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Michitaro Fujimoto (4 out of 4 patents)

silverMedal Ling Jin (3 out of 6 patents)

bronzeMedal Hisanao Hiramatsu (3 out of 3 patents)

4.  Takeshi Sakai (3 out of 4 patents)

5.  Hirokazu Seki (3 out of 3 patents)

6.  Shuhei Takamatsu (3 out of 3 patents)

7.  Yoshikazu Nakamura (2 out of 14 patents)

8.  Giichi Funazo (2 out of 2 patents)

9.  Kentaro Hotta (1 out of 3 patents)

10.  Hiroshi Handa (1 out of 19 patents)

11.  Takumi Itoh (1 out of 11 patents)

12.  Shin Miyakawa (1 out of 7 patents)

13.  Hideki Ando (1 out of 35 patents)

14.  Masatoshi Fujiwara (1 out of 32 patents)

15.  Yoshikazu Funazo (1 out of 1 patent)


8 patents:

Company Overview
Fujimoto Pharmaceutical Corporation is a leading Japanese pharmaceutical company specializing in the research, development, and manufacture of innovative medications. With a focus on addressing unmet medical needs, Fujimoto Pharma is committed to producing high-quality, safe, and effective treatments for a wide range of health conditions. Visit our website to learn more about our products and services.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#543 in Osaka

#5,049 in Japan

Osaka, JP
Osaka, Japan
Forward Citations = 34

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fujimoto Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/fujimoto-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…